Virtual Shareholders Meeting
On 20 April 2020, AVITA Medical announced its intention to redomicile AVITA Medical and its subsidiaries (Avita Group) from Australia to the United States of America by way of a scheme of arrangement under which AVITA Therapeutics, Inc., a newly-formed company incorporated in Delaware in the United States of America, will become the parent company of the Avita Group (Scheme).
On 11 May 2020, the Federal Court of Australia approved orders to convene a general meeting of AVITA Medical’s shareholders at 9:00am (AEST) on Monday, 15 June 2020 for the purpose of considering a resolution to approve the Scheme (Scheme Meeting).
In light of the restrictions imposed by Australian governments in response to COVID-19, the Scheme Meeting will be conducted exclusively as a virtual meeting by way of a live webcast. Taking part in the live webcast will enable shareholders to listen to the Scheme Meeting live, view slides and proxy results and to also ask questions and cast their vote at the appropriate times whilst the Scheme Meeting is in progress.
Shareholders who are registered as at 9:00am (AEST) on Saturday, 13 June 2020 in AVITA Medical’s share register will be entitled to vote at the live webcast of the Scheme Meeting. Shareholders can access the live webcast by following the instructions below.